https://www.zacks.com/stock/news/2312272/ensign-group-ensg-q2-earnings-beat-on-occupancy-stock-up-7-2?cid=CS-ZC-FT-analyst_blog|earnings_article-2312272
Jul 30, 2024 - Ensign Group's (ENSG) second-quarter results benefit from improved occupancy and skilled services revenue. Higher expenses partially offset the results.
zc:4896351413388913399
0
https://www.zacks.com/stock/news/2309263/universal-health-uhs-q2-earnings-beat-on-acute-care-strength?cid=CS-ZC-FT-analyst_blog|earnings_article-2309263
Jul 25, 2024 - Universal Health's (UHS) second-quarter results benefit from the rising number of patients in the Acute Care Unit. Declining admissions in the Behavioral Health segment partially offset the positives.
zc:-1103559849370680575
0
https://www.zacks.com/stock/news/2308089/tenet-thc-q2-earnings-beat-on-patient-volumes-24-eps-view-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2308089
Jul 24, 2024 - Tenet Healthcare's (THC) Q2 results reflect net revenue per case growth, higher pricing yield and a decline in overall expenses. It expects 2024 adjusted EPS within $10.41-$11.12, up from the previous guidance of $8.37-$9.41.
zc:4123759753264687110
0
https://www.zacks.com/commentary/2304617/q2-earnings-season-scorecard-economic-outlook-and-analyst-reports-for-nvidia-meta-others?cid=CS-ZC-FT-research_daily-2304617
Jul 18, 2024 - Today's Research Daily features the Q2 earnings season scorecard and fresh research reports on NVIDIA (NVDA), Meta (META), Amgen and others.
zc:4490964629599702270
0
https://www.zacks.com/stock/news/2303869/elevance-health-s-elv-q2-earnings-beat-on-lower-benefit-expense?cid=CS-ZC-FT-analyst_blog|earnings_article-2303869
Jul 17, 2024 - Elevance Health's (ELV) Q2 results gain on strong product revenue growth in the Carelon business and a reduced overall expense level. Adjusted earnings are reiterated to be at a minimum of $37.20 per share in 2024.
zc:7643414758751539707
0
https://www.zacks.com/stock/news/2303715/unitedhealth-rises-on-q2-earnings-beat-etfs-to-gain?cid=CS-ZC-FT-etf_news_and_commentary-2303715
Jul 17, 2024 - UnitedHealth Group (UNH) reported better-than-expected second-quarter 2024 results as it breezed past the Zacks Consensus Estimate on both earnings and revenues.
zc:1139044798695318301
0
https://www.fool.com/earnings/call-transcripts/2024/07/16/unitedhealth-group-unh-q2-2024-earnings-call-trans/?source=iedfolrf0000001
Jul 16, 2024 - UNH earnings call for the period ending June 30, 2024.
0
fool:9208434553639681788
0
https://www.zacks.com/stock/news/2302909/unitedhealth-group-unh-q2-earnings-beat-on-strong-optum-unit?cid=CS-ZC-FT-analyst_blog|earnings_article-2302909
Jul 16, 2024 - UnitedHealth Group's (UNH) second-quarter earnings continue to be supported by strong Optum and UnitedHealthcare business lines. Rising medical costs partially offset the positives.
zc:3105269088339399999
0
https://www.zacks.com/stock/news/2302907/unitedhealth-unh-reports-q2-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2302907
Jul 16, 2024 - The headline numbers for UnitedHealth (UNH) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:-7753135104867557138
0
https://seekingalpha.com/article/4704382-unitedhealth-group-incorporated-unh-q2-2024-earnings-call-transcript?source=feed_sector_transcripts
Jul 16, 2024 - UnitedHealth Group Incorporated (NYSE:NYSE:UNH) Q2 2024 Earnings Call Transcript July 16, 2024 8:45 AM ETCompany ParticipantsAndrew Witty - CEOJohn Rex -...
0
sa:-2733656709275184627
0